KCG Holdings Inc. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 39.5% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,100 shares of the company’s stock after selling 5,289 shares during the period. KCG Holdings Inc.’s holdings in Cardinal Health were worth $661,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Advisory Services Network LLC purchased a new position in shares of Cardinal Health during the first quarter valued at $120,000. Quadrant Capital Group LLC boosted its position in shares of Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock valued at $156,000 after buying an additional 116 shares during the last quarter. Alpha Windward LLC boosted its position in shares of Cardinal Health by 1.8% in the first quarter. Alpha Windward LLC now owns 2,282 shares of the company’s stock valued at $186,000 after buying an additional 41 shares during the last quarter. MCF Advisors LLC boosted its position in shares of Cardinal Health by 11.5% in the first quarter. MCF Advisors LLC now owns 2,478 shares of the company’s stock valued at $202,000 after buying an additional 256 shares during the last quarter. Finally, First Mercantile Trust Co. boosted its position in shares of Cardinal Health by 18.5% in the first quarter. First Mercantile Trust Co. now owns 2,539 shares of the company’s stock valued at $207,000 after buying an additional 397 shares during the last quarter. 87.63% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cardinal Health, Inc. (NYSE CAH) traded up 1.32% during trading on Friday, hitting $77.61. The stock had a trading volume of 1,296,671 shares. The stock’s 50-day moving average price is $77.25 and its 200-day moving average price is $77.19. Cardinal Health, Inc. has a one year low of $62.70 and a one year high of $85.52. The company has a market cap of $24.52 billion, a P/E ratio of 18.53 and a beta of 0.81.
Cardinal Health (NYSE:CAH) last announced its earnings results on Monday, May 1st. The company reported $1.53 EPS for the quarter, beating the consensus estimate of $1.46 by $0.07. The business had revenue of $31.82 billion for the quarter, compared to the consensus estimate of $32.30 billion. Cardinal Health had a return on equity of 25.78% and a net margin of 1.05%. The company’s revenue was up 3.8% on a year-over-year basis. During the same period last year, the business posted $1.43 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post $5.35 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Saturday, July 15th. Investors of record on Monday, July 3rd were issued a dividend of $0.4624 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.45. This represents a $1.85 annualized dividend and a dividend yield of 2.38%. The ex-dividend date was Thursday, June 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 44.05%.
COPYRIGHT VIOLATION WARNING: This article was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2017/07/30/kcg-holdings-inc-reduces-position-in-cardinal-health-inc-cah-updated-updated-updated.html.
Several brokerages recently issued reports on CAH. Credit Suisse Group restated an “outperform” rating and issued a $87.00 price objective (up from $81.00) on shares of Cardinal Health in a report on Thursday, July 13th. William Blair lowered shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, April 19th. Barclays PLC restated an “overweight” rating and issued a $82.00 price objective (down from $88.00) on shares of Cardinal Health in a report on Saturday, April 22nd. BidaskClub lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Finally, Jefferies Group LLC began coverage on shares of Cardinal Health in a report on Wednesday, May 17th. They issued a “hold” rating and a $77.00 price objective on the stock. One research analyst has rated the stock with a sell rating, seventeen have issued a hold rating and four have assigned a buy rating to the company’s stock. Cardinal Health currently has an average rating of “Hold” and a consensus price target of $82.99.
In related news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the firm’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the sale, the insider now directly owns 55,440 shares in the company, valued at approximately $4,039,912.80. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.94% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.